COMMUNIQUÉS West-GlobeNewswire

Renovaro Announces $15 million in Equity Committed

26/02/2025 - 15:15

LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announces that it has $15 million in additional [...]

LiveWorld Expands Board of Directors, Adding Healthcare & Tech Executive Carl Gustin

26/02/2025 - 15:00

Marketing innovator Mr. Gustin to drive LiveWorld’s AI-powered growth CAMPBELL, Calif., and NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), a leading social-first digital agency [...]

Philips accelerates precise imaging with unique AI technologies in MRI to improve patient outcomes

26/02/2025 - 15:00

February 26, 2025 Philips integrates advanced AI algorithms into its MRI systems, featuring Dual AI-driven engines in SmartSpeed Precise [1] to enable faster scanning Innovations include the latest AI-enabled MR [...]

ONE Retreats’ Transformative Psilocybin Wellness Initiative Addresses Mental Health Conditions for Veterans

26/02/2025 - 15:00

SEAL Future Foundation joins forces to expand safe access to psychedelic-assisted therapies “Guidance Integration Platform” to provide integration resources for the patient community RUNAWAY BAY, Jamaica, Feb. 26, 2025 [...]

Jasper Therapeutics to Present at Upcoming March Investor Conferences

25/02/2025 - 22:30

REDWOOD CITY, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]

Ardelyx to Participate in Upcoming Investor Conferences

25/02/2025 - 22:15

WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]

ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones

25/02/2025 - 22:15

Anticipated registrational development plans for ORIC-944 and ORIC-114 prioritized to focus on indications with strongest clinical validation and highest unmet need ORIC-944 initiation of first Phase 3 trial in mCRPC [...]

Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia

25/02/2025 - 22:10

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T ™ ) products [...]

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

25/02/2025 - 22:10

Ji’an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the [...]

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

25/02/2025 - 22:05

PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]

Vagus Nerve Society to host a webinar, “VNS as a Tool to Improve Focus, Energy, and Readiness in Today’s Warfighter”

25/02/2025 - 22:05

JACKSONVILLE, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- The Vagus Nerve Society, the preeminent association dedicated to ongoing education and training in the power of the vagus nerve, is pleased to announce its upcoming [...]

Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results

25/02/2025 - 22:05

SUNNYVALE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]

Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston

25/02/2025 - 22:05

WEST CHESTER, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring [...]

Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress

25/02/2025 - 22:05

Achieved Q4 2024 and full year 2024 OJEMDA™ (tovorafenib) net product revenues of $29.0 million and $57.2 million, respectively Ended 2024 with $531.7 million in cash, cash equivalents and short-term investments Company [...]

Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance

25/02/2025 - 22:05

Fourth Quarter Highlights† Reported revenue of $355.2 million, up 9.4% Constant currency revenue* and constant currency revenue, organic* up 10.1% and up 6.1%, respectively GAAP operating margin of 10.3%, compared to 10 [...]

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

25/02/2025 - 22:05

ALISO VIEJO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]

Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025

25/02/2025 - 22:05

CARLSBAD, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December 31, 2024, before the market [...]

Bolt Biotherapeutics to Participate in Upcoming March Conferences

25/02/2025 - 22:05

REDWOOD CITY, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that [...]

OraSure Reports Fourth Quarter 2024 Financial Results

25/02/2025 - 22:05

BETHLEHEM, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for [...]